Curaleaf (OTCMKTS:CURLF) Trading Up 7.8% – Should You Buy?

Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLF) traded up 7.8% during mid-day trading on Tuesday . The company traded as high as $11.31 and last traded at $11.26. Approximately 105,528 shares traded hands during trading, a decline of 64% from the average daily volume of 293,632 shares. The stock had previously closed at $10.45.

Analyst Upgrades and Downgrades

Several analysts have issued reports on CURLF shares. Citigroup reaffirmed a “buy” rating on shares of Curaleaf in a research report on Thursday, August 6th. Zacks Research raised Curaleaf from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 14th. Three research analysts have rated the stock with a Strong Buy rating and two have assigned a Buy rating to the stock. According to MarketBeat, Curaleaf currently has an average rating of “Strong Buy”.

Curaleaf Stock Performance

The stock has a 50-day simple moving average of $9.53 and a 200-day simple moving average of $8.28. The stock has a market cap of $2.60 billion, a P/E ratio of -85.76 and a beta of 1.57. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.52 and a quick ratio of 0.73.

Curaleaf (OTCMKTS:CURLF) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.25. Curaleaf had a negative return on equity of 0.88% and a negative net margin of 2.62%.The company had revenue of $340.10 million for the quarter, compared to the consensus estimate of $332.00 million. Research analysts forecast that Curaleaf Holdings, Inc. will post 0.01 earnings per share for the current year.

About Curaleaf

Curaleaf Holdings, Inc is a cannabis company that cultivates, processes, distributes and sells cannabis products in the United States and select international markets. Its operations include cannabis cultivation and processing facilities, retail dispensaries and wholesale distribution, serving both medical cannabis patients and adult-use consumers where permitted by law.

The company offers a broad portfolio of products, including cannabis flower, pre-rolls, vape products, concentrates, edibles, tinctures and other wellness-oriented products.